Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 2
1948 3
1950 1
1951 5
1992 1
1994 1
1996 2
1997 4
1999 1
2000 1
2001 2
2002 2
2005 1
2009 3
2010 5
2011 8
2012 4
2013 7
2014 6
2015 3
2016 2
2018 1
2019 4
2021 1
2022 8
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial.
González-Martín A, Desauw C, Heitz F, Cropet C, Gargiulo P, Berger R, Ochi H, Vergote I, Colombo N, Mirza MR, Tazi Y, Canzler U, Zamagni C, Guerra-Alia EM, Levaché CB, Marmé F, Bazan F, de Gregorio N, Dohollou N, Fasching PA, Scambia G, Rubio-Pérez MJ, Milenkova T, Costan C, Pautier P, Ray-Coquard I; PAOLA1/ENGOT-ov25 investigators. González-Martín A, et al. Among authors: bazan f. Eur J Cancer. 2022 Oct;174:221-231. doi: 10.1016/j.ejca.2022.07.022. Epub 2022 Sep 5. Eur J Cancer. 2022. PMID: 36067615 Free article. Clinical Trial.
Bazan F, Radosevic A, Aguilar G, Sanchez J. Bazan F, et al. Cir Esp. 2014 Oct;92(8):e45. doi: 10.1016/j.ciresp.2014.03.006. Epub 2014 May 23. Cir Esp. 2014. PMID: 24862685 English, Spanish. No abstract available.
Chemotherapy-induced secondary pneumothorax.
Bazan F, Vollmer I, Gayete A. Bazan F, et al. Arch Bronconeumol. 2014 Jan;50(1):44. doi: 10.1016/j.arbres.2013.06.007. Epub 2013 Oct 8. Arch Bronconeumol. 2014. PMID: 24119689 English, Spanish. No abstract available.
Cabazitaxel: a novel microtubule inhibitor.
Villanueva C, Bazan F, Kim S, Demarchi M, Chaigneau L, Thiery-Vuillemin A, Nguyen T, Cals L, Dobi E, Pivot X. Villanueva C, et al. Among authors: bazan f. Drugs. 2011 Jul 9;71(10):1251-8. doi: 10.2165/11591390-000000000-00000. Drugs. 2011. PMID: 21770474 Review.
The CD40 antigen and its ligand.
Banchereau J, Bazan F, Blanchard D, Brière F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S. Banchereau J, et al. Among authors: bazan f. Annu Rev Immunol. 1994;12:881-922. doi: 10.1146/annurev.iy.12.040194.004313. Annu Rev Immunol. 1994. PMID: 7516669 Review.
Safety profile of new anticancer drugs.
Mansi L, Thiery-Vuillemin A, Nguyen T, Bazan F, Calcagno F, Rocquain J, Demarchi M, Villanueva C, Maurina T, Pivot X. Mansi L, et al. Among authors: bazan f. Expert Opin Drug Saf. 2010 Mar;9(2):301-17. doi: 10.1517/14740330903530663. Expert Opin Drug Saf. 2010. PMID: 20175699 Review.
[Imaging renal cell carcinoma].
Bazan F, Busto M. Bazan F, et al. Radiologia. 2014 Jan-Feb;56(1):61-75. doi: 10.1016/j.rx.2013.08.005. Epub 2013 Nov 21. Radiologia. 2014. PMID: 24268598 Free article. Review. Spanish.
Safety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor-Positive Recurrent or Metastatic Endometrial Cancer: The VICTORIA Multicenter, Open-label, Phase 1/2 Randomized Clinical Trial.
Heudel P, Frenel JS, Dalban C, Bazan F, Joly F, Arnaud A, Abdeddaim C, Chevalier-Place A, Augereau P, Pautier P, Chakiba C, You B, Lancry-Lecomte L, Garin G, Marcel V, Diaz JJ, Treilleux I, Pérol D, Fabbro M, Ray-Coquard I. Heudel P, et al. Among authors: bazan f. JAMA Oncol. 2022 Jul 1;8(7):1001-1009. doi: 10.1001/jamaoncol.2022.1047. JAMA Oncol. 2022. PMID: 35551299 Free PMC article. Clinical Trial.
71 results